Laurus Labs gets license to manufacture, market 2-Deoxy-D-Glucose in India

02 Jul 2021 Evaluate

Laurus Labs has received the licence from Defence Research & Development Organisation (DRDO) to manufacture and market of 2- Deoxy-D-Glucose (2DG). 2DG has been given emergency approval by the Drug Controller General of India (DCGI) for use on COVID-19 patients in the country.

Laurus Labs has already applied with CDSCO for emergency use authroisation (EUA) for 2DG. 

Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of APIs for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas.

Laurus Labs Share Price

604.20 1.85 (0.31%)
01-Jan-2025 09:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1886.45
Dr. Reddys Lab 1390.95
Cipla 1529.05
Lupin 2350.95
Zydus Lifesciences 969.05
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.